As I said, you're right. We have data up to two months on, including data for long-term care facility residents, in whom the vaccine effectiveness is above 80%. In that data, we don't see a decline of vaccine effectiveness over time, up to two months.
What the modelling has shown us is that even if we were to include a 5% decline of vaccine effectiveness over time, the benefit in terms of a decrease in hospitalizations and mortality at the Canadian level would still be beneficial.